Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part A

Niccolo Bartalucci practices in Florence, Italy. Dr. Bartalucci is highly rated in 6 conditions, according to our data. His top areas of expertise are Essential Thrombocythemia, Myelofibrosis, Polycythemia Vera, and Splenomegaly. His clinical research consists of co-authoring 34 peer reviewed articles in the past 15 years. Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals:OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.

• PrefaceNiccolò Bartalucci and Lorenzo Galluzzi1. Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entitiesGiacomo Coltro, Giuseppe Gaetano Loscocco and Alessandro M. Vannucchi2. Bone marrow microenvironment of MPN cellsAlessandro Malara,Christian A. Di Buduo,Vittorio Abbonante and Alessandra Balduini3. Extramedullary hematopoiesis in myeloproliferative neoplasms: Pathophysiology and treatment strategiesBrian J Chernak and Raajit K Rampal4. The JAK2 mutationSalma Merchant5. The MPL mutationPaola Guglielmelli and Laura Calabresi6. Calreticulin mutations in myeloproliferative neoplasmsKotaro Shide